Thromboprophylaxis for children hospitalized with COVID‐19 and MIS

Por um escritor misterioso

Last updated 08 novembro 2024

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS

Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative Review

Post-acute COVID-19 syndrome

Routine primary thromboprophylaxis with enoxaparin safe in children with COVID-19 or MIS-C

Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021

MIS-C Associated with COVID-19 Anti-thrombosis Guideline of Care for Children - Advanced Cardiac Therapies Improving Outcomes Network

Frontiers Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review

Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021

Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis

Systemic and organ-specific immune-related manifestations of COVID-19

Pathogens, Free Full-Text

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library

Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium - eClinicalMedicine

Clot Chronicles: Thrombosis in Hospitalized Pediatric Patients with COVID-19 and MIS-C

Recomendado para você